Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2011 08:25 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals' TH-302 Continues to Demonstrate Promising Activity in Pancreatic Cancer Phase 1/2 Clinical Trial

REDWOOD CITY, Calif., Jan. 24, 2011 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage...
December 22, 2010 08:35 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces Promising Early Phase 1 Clinical Trial Results in Patients With Advanced Leukemias

REDWOOD CITY, Calif., Dec. 22, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced a preclinical collaboration with the MD Anderson Cancer Center and early Phase 1...
November 18, 2010 08:25 ET | Source: Threshold Pharmaceuticals, Inc.

Follow-up Data From Threshold Pharmaceuticals' Phase 1/2 Clinical Trials of TH-302 Demonstrate Broad Activity in All Combinations Against Multiple Tumor Types

REDWOOD CITY, Calif., Nov. 18, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced clinical trial results related to Threshold's clinical stage hypoxia-activated...
November 12, 2010 08:25 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Presents Promising Data From a Phase 1/2 Clinical Trial of TH-302 at International Sarcoma Meeting

REDWOOD CITY, Calif., Nov. 12, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced clinical trial results related to Threshold's clinical stage hypoxia-activated...
November 09, 2010 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Announces Additional Medical and Investor Conference Presentations

REDWOOD CITY, Calif., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced additional meetings to its Fall conference presentation schedule. The Company will...
November 04, 2010 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Third Quarter 2010 Financial and Operational Results

REDWOOD CITY, Calif., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the third quarter ended September 30, 2010. The net loss...
November 03, 2010 09:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Awarded $488,958 in Grants Under Qualifying Therapeutic Discovery Project Program

REDWOOD CITY, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today announced that the Company has been awarded a total of $488,958 in grants under the...
October 12, 2010 08:30 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Presents Follow-Up Data From a Phase 1/2 Clinical Trial of TH-302 in Solid Tumors

REDWOOD CITY, Calif., Oct. 12, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced interim results from an ongoing Phase 1/2 clinical trial in various solid tumors...
September 08, 2010 09:15 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold to Present at Rodman & Renshaw Healthcare Conference

REDWOOD CITY, Calif., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that Dr. Barry Selick, Threshold's chief executive officer, will present at the...
August 05, 2010 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Second Quarter 2010 Financial and Operational Results

REDWOOD CITY, Calif., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), today reported financial results for the second quarter ended June 30, 2010. The net loss for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right